#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoinflammation with infantile enterocolitis Primary adrenal insufficiency Immunodeficiency common variable MELAS syndrome Metastases to central nervous system Follicular lymphoma stage I Cholangiosarcoma Neuronal ceroid lipofuscinosis Cardiac failure acute IPEX syndrome Staphylococcal infection Severe myoclonic epilepsy of infancy Malignant central nervous system neoplasm Systemic candida Hepatitis D More trials…

    Learn about Rare Diseases

    CADASIL – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Cytokine release syndrome – Basic Information Retinoblastoma – Trials in Disease Cholangitis sclerosing Turner’s syndrome Hepatoblastoma Synovial sarcoma recurrent – Trials in Disease Angiosarcoma metastatic – Treatment Mucopolysaccharidosis II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pelareorep Ibuprofen Sodium Dihydrate Epinephrine Bitartrate RLY-2608 Efpegerglucagon Cefazolin Phentermine Vortioxetine Hydrobromide Mycophenolic Acid 12 Grass Pollen Mixture Trometamol CARBACHOL 4-Hydroxy-N-Desmethyltamoxifen Pal1-15 Acetate Dcc-3116 Zinc Acexamate Opevesostat Tosilate Medi0618 Amitriptyline Hydrochloride F125/10 More therapies…

    Learn about Your Condition

    Hyponatraemia Neurofibrosarcoma Leukoencephalopathy Tetanus Multiple sclerosis relapse Epileptic encephalopathy Iron overload Breast cancer in situ Substance use disorder Brain neoplasm malignant Cutaneous calcification Tendon injury Biliary neoplasm Prostate cancer metastatic Colorectal adenoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

    Recruiting

    2 1
    Bulgaria Czechia France Hungary Poland Spain
  • Study of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glomerulonephritis membranous
    • Nephrotic syndrome
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • Atacicept
    Belgium France Germany Italy Poland Spain
  • Study of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Azathioprine
    • Methylprednisolone Hydrogen Succinate
    • Sirolimus
    France
  • Study of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Arginine Hydrochloride
    • Dimeticone
    • Lysine Hydrochloride
    France Germany Hungary Italy The Netherlands Poland +1
  • Study of intramuscular methylprednisolone acetate to treat pain in patients with hand osteoarthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Sodium Chloride
    • Methylprednisolone Acetate
    The Netherlands
  • Study of baricitinib versus placebo for treating polymyalgia rheumatica in adult patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polymyalgia rheumatica
    Investigated Drugs:
    • Baricitinib
    France
Previous Page
1 … 156 157 158 159 160 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!